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ABSTRACT 
The objective of the present study was to synthesize some new 7-sulfonate of 2, 3- Diphenyl quinoxaline which are more potential as 
antibacterial than parent quinoxalines. The present study was synthesis of derivatives of sulfonyl chloride quinoxaline and physicochemical and 
spectral characterization, in vitro antimicrobial screening against gram positive and gram negative bacteria.The concentratio n of derivatives 
used as 200 and 400 microgram initially. When 200 µg concentrations was used R6 shows sensitivity towards S. aureus and R6 shows 
sensitivity towards gram negative E. coli organism. When 400 µg used then R3, R5, and R6 shows sensitivity in case of gram positive organism. 
And in case of gram negative organism R5, R6 shows sensitivity.Azithromycin is used as Reference  drug and a comparative study was done. As 
compare to reference drug all derivatives shows less sensitivity than S- Standard and R- quinoxaline derivatives. 
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1. INTRODUCTION: 
Quinoxaline is also called as benzopyrazine. It is heterocyclic 
compound containing benzene ring & pyrazine ring. Pyrazine 
are stable, colorless compound which are soluble in water. 
Unlike pyridine, they are expensive & not readily available & 
so are seldom used as starting material for synthesis of their 
derivative. Diazines are fused to benzene ring to form 
quinoxaline. The pyrazine ring system is found in the fungal 
metabolite aspergillic acid and in dihydro form in luciferin of 
several bettles including the fire fly is responsible for the 
chemiluminescence of this ostracod. Methoxy pyrazine are 
very important component of aroma of many fruit’s and 
vegetable such as Peas and Capsicum peppers and also of 
wines. 
Antimicrobial agent shows activity against bacteria, fungi, 
mycobacterium species, called antibacterial, antifungal, 
antituberculer activity respectively. There are various 
quinoxaline derivatives showing antimicrobial activity. 
Quinoxaline core antibiotics like Echinomycin, Triostin A 
showing antimicrobial activity by having DNA cleaving 
property. Design of quinoxaline antibiotics have undertaken 
by several workers, but they posses limited application due 
to their toxic effect. It is believed that the antimicrobial 
potency of the quinoxaline due to the facilitate approach of 
the structure to prevent DNA directed RNA synthesis by 
virtue binding to CPG site on DNA (Ali et.al, 2003). 
Ganapaty et.al., 2007 has synthesized some new 2-
substituted hydrazino/benzylidino/methyl hydrazones and 
7-sulfonamides of 1H, 4H 3-oxo-quinoxalines from 1H, 4H-
quinoxalin-2,3diones. All the compounds were evaluated for 
their in vitro antimicrobial activity against the gram-positive 
bacteria Staphyllococus aureus, the gram-negative 
Psudomonas aeruginosa, Proteus vulgaris and Escherichia coli, 
the fungi Aspergillus niger, Candida albicans and the 
Mycobacterium tuberculosisH37Rv species. Antibacterial and 
antifungal screening was carried out by agar plate disc 
diffusion method at 100µg/disc concentration in triplicate 
and its results were reported as zone of inhibition in 
millimeter. The antituberculer screening was performed by 
Micro plate Alamar Blue Assay method.      
M. M. Ali synthesized some novel quinoxalinone derivatives.i 
The antimicrobial activities of the synthesized compounds 
were determined by the agar diffusion technique. The 
organisms tested were Staphyloccus aureus ( NCTC 7447 ), 
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Bacillus cereus (ATCC-14579 ), Serratia marcescens ( IMRU 
70 ), Proteus merabitis ( NCTC-289 ), Aspergillus ochraceus, 
Wilhelm ( AUCC-230 ) and Penicillium chrysogenum, Thom ( 
AUCC-530 ).  Disk diffusion refers to the diffusion of an 
antimicrobial agent of a specified concentration from disks, 
tablets or strips, into the solid culture medium that has been 
seeded with the selected inoculum isolated in a pure culture. 
Disk diffusion is based on the determination of an inhibition 
zone proportional to the bacterial susceptibility to the 
antimicrobial present in the disk. 
The diffusion of the antimicrobial agent into the seeded 
culture media results in a gradient of the antimicrobial. 
When the concentration of the antimicrobial becomes so 
diluted that it can no longer inhibit the growth of the test 
bacterium, the zone of inhibition is demarcated. The 
diameter of this zone of inhibition around the antimicrobial 
disk is related to minimum inhibitory concentration (MIC) 
for that particular bacterium/antimicrobial combination; the 
zone of inhibition correlates inversely with the MIC of the 
test bacterium. Generally, the larger the zone of inhibition, 
the lower the concentration of antimicrobial required to 
inhibit the growth of the organisms. However, this depends 
on the concentration of antibiotic in the disk and its 
diffusibility. 
Quinoxalines are becoming the attractive target of extensive 
research due to its inherent diverse properties. Various 
potential activities of the quinoxalines have been explored 
recently like, antimicrobial agents, cytotoxic agents, anti-
tubercular, anxiolytic, anti-HIV, anti-inflammatory, 
antioxidant etc. In the recent year, 2, 3 Disubstituted 
quinoxalines reported to posse’s significant antimicrobial 
potential against bacteria, fungi, and mycobacterium 
(Ganapaty S. et al 2007). Design of quinoxaline antibiotics 
have undertaken by several workers, but they posses limited 
application due to their toxic effect. According to conclusion 
derived in literature survey, it was worthwhile to introduced 
lipophillic moiety into the 2,3 diphenyl quinoxaline system to 
make the structure as DNA targeted potent antimicrobial 
agent the sulfonate have created considerable attention as 
carrier and lipophillic core in the area of synthetic medicinal 
chemistry. Based on the observation and in connection with 
earlier studies (Ganapaty etal, 2007), the present work was 
undertaken synthesize some new phenol & aldehyde  
derivatives of 2, 3 diphenylquinoxaline 7 sulphonyl chloride 
which are more potential as antibacterial than parent 
quinoxalines.
  
 
 
2. MATERIAL AND METHODS: 
2.1 Scheme of synthesis 
NH2
NH2
+ O
O
Ethanol
Heat for 30 min.
N
N
ClSO3H
N
N S
O
O
Cl
benzene-1,2-diamine 1,2-diphenylethane-1,2-dione
2,3-diphenylquinoxaline
2,3-diphenylquinoxaline-7-Sulphonyl Chloride  
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2.2 Derivatives of 2,3-diphenylquinoxaline-7-sulphonyl chloridewithPhenol 
 
 
2.3 Experimental Procedure: 
2.3.1 Synthesis of 2, 3-diphenylquinoxaline 
To warm solution of 4.2 gram of benzyl in 16 ml of rectified 
spirit, the solution of 2.2ml of o-phelyne diamine in 16 ml of 
rectified spirit was added & combine solution was warm in 
water wath for 30 min. added water until slight colourless 
persist & allow to cool. Filter & recrystallize the product in 
ethanol.      
2.3.2 Synthesis of  2-hydroxyphenyl-2,3-
diphenylquinoxaline-7-sulphonate(R1) 
Mix 1.17gm of  resorcinol with 3ml pyridine & 2.34 gm of 
sulphonyl chloride derivative &heat on water bath for 1 hr. 
pour into 25 ml of cold water & stir until the oil solidifies , 
filter wash with cold dil HCl to remove pyridine and cold dil 
NaOH  to remove any phenol present &them with cold water 
, recrystallized from methanol or ethanol. 
2.3.3Synthesis of Phenyl-2,3-diphenylquinoxaline-7-
sulphonate(R2) 
Mix 1 gm of  phenol with 2.5ml pyridine & 2 gm of sulphonyl 
chloride derivative & heat on water bath for 1 hr. pour into 
25 ml of cold water & stir until the oil solidifies , filter wash 
with cold dil HCl to remove pyridine and cold dil NaOH  to 
remove any phenol present &them with cold water , 
recrystallized from methanol or ethanol. 
2.3.4Synthesis of 4-hydroxyphenyl-2,3-
diphenylquinoxaline-7-sulphonate(R3) 
Mix 1.17 gm of  quinol with 3ml pyridine & 2.34 gm of 
sulphonyl chloride derivative &heat on water bath for 55min 
pour into 25 ml of cold water & stir until the oil solidifies , 
filter wash with cold dil HCl to remove pyridine and cold dil 
NaOH  to remove any phenol present & them with cold water 
, recrystallized from methanol or ethanol. 
4.3.2.4 Synthesis of 4-Chlorophenyl-2,3-
diphenylquinoxaline-7-sulphonate(R4) 
 Mix 1.36 gm of 4-chloro  phenol with 3.4ml pyridine & 2.72 
gm of sulphonyl chloride derivative &heat on water bath for 
1 hr. pour into 25 ml of cold water & stir until the oil 
solidifies , filter wash with cold dil HCl to remove pyridine 
and cold dil NaOH  to remove any phenol present &them 
with cold water , recrystallized from methanol or ethanol. 
2.3.5 Synthesis of Napthalene-1-yl-2,3-
diphenylquinoxaline-7-sulphonate(R5) 
Mix 1.54gm of  1-naphthol with 3.85ml pyridine & 3.08 gm of 
sulphonyl chloride derivative &heat on water bath for 2 hr. 
pour into 25 ml of cold water & stir until the oil solidifies , 
filter wash with cold dil HCl to remove pyridine and cold dil 
NaOH  to remove any phenol present &them with cold water, 
recrystallized from methanol or ethanol. 
2.3.6 Synthesis of Napthalene-2-yl-2,3-
diphenylquinoxaline-7-sulphonate (R6) 
Mix 1.54 gm of  2-naphthol with 3.85ml pyridine & 3.08 gm 
of sulphonyl chloride derivative &heat on water bath for 2.15 
hr. pour into 25 ml of cold water & stir until the oil solidifies , 
filter wash with cold dil HCl to remove pyridine and cold dil 
NaOH  to remove any phenol present &them with cold water, 
recrystallized from methanol or ethanol. 
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2.4 Physical Properties  
Synthesized quinoxaline sulfonamide derivatives were 
evaluated for physical properties such as physical state, 
color, and melting point. 
2.4.1 Melting point 
Melting points of all derivatives were determined by Open 
capillary tube method. 
2.4.2 Solubility 
Solubility study of synthesized derivatives was carried out in 
different solvents like water, ethanol, methanol, acetone, 
benzene, chloroform, and DMF. 
2.4.3 Thin layer chromatography (TLC) 
All the synthesized derivatives were subjected to TLC 
analysis to ensure the completion of the reaction  
2.5 Characterization of Synthesized Compounds: 
The identification & characterization of prepared compound 
were carried out on the basis of spectral data such as 
Infrared Spectroscopy (IR), Mass Spectrometry (MS), Nuclear 
Magnetic Resonance Spectroscopy (1HNMR). 
3. ANTIMICROBIAL ACTIVITY: 
3.1 Determination of minimum inhibitory concentration 
3.1.1 Tube dilution technique 
Preparation of media: 
Double strength nutrient broth was prepared by dissolving 
6.25 g of nutrient broth in 250 ml distilled water. The 
medium was boiled to aid dissolution and sterilized by 
autoclaving at 15 psi pressure (121˚C) for 20 min. 
1ml of double strength nutrient broth was added to a set of 
presterilized 5 test tubes (numbered from 1-5). To the first 
test tube, 1ml quinoxaline derivative sample solution 
(conc.=1000 µg/ml) was added. After thorough mixing, 1ml 
of solution from test tube no.1 was transferred to test tube 
no.2 so as to obtain concentration of 500µg/ml. The same 
procedure (serial dilution) was followed forthe remaining 
test tubes from no. 3 to no. 5 to get the concentration in the 
range of 250µg/ml to 62.5 µg/ml from 3rd to 5th test tube. 
From 5th test tube1 ml of solution wasdiscarded so as to get 
the equal volume in each test tube. Thus, each tube 
havingconcentration of 1000, 500, 250, 125, 62.5µg/ml. To 
each test tube 20 µl of Enterobacteria suspension was added 
(inoculation). All test tubes were incubated at 37˚C for 24 
hours and observed for turbidity. The sets of test tube were 
compared for determining the MIC. The whole experimental 
setup was repeated for S. aureus and E. coli. 
Table 1: Experimental set up for MIC (S. aureus) 
Micro-organism S. aureus 
Media 
Double strength 
nutrient broth 
Conc. of quinoxaline derivative 1000µg/ml 
Loaded volume of media 1 ml 
Loaded volume of microbial suspension 20 µl 
Incubation temperature 37°C 
Incubation period 24 Hrs 
 
 
4. RESULT AND DISCUSSION: 
4.1 Raw material characterization 
Table 2: Raw material characterization 
Sr. no. Name Mol. Formula Mol. Wt. M.P. B.P. 
1 Benzil C14H10O2 210.23 93-95 - 
2 O- phenylene diamine C6H8N2 108.14 104 - 
3 Chlorosulfonic acid HClO3S 116.52 80 151-152 
4 Phenol C6H6O 94.11 - 180-182 
5 Resorcinol C6H6O2 110.11 109-111 - 
6 Quinol C6H6O2 110.11 170-174 - 
7 4-Cl Phenol C6H5OCl 128.5  220- 
8 α-Naphthol C10H8O 144.17 96 288 
9 β- Naphthol C10H9O 144.17 121-123 285-286 
 
NH2
NH2
+ O
O
Ethanol
Heat for 30 min.
N
N
benzene-1,2-diamine
2,3-diphenylquinoxaline
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4.2 Synthesis of phenol derivatives of  2,3-diphenylquinoxaline-7-sulphonyl chloride 
4.2.1 Synthesis of  2-hydroxyphenyl-2,3-diphenylquinoxaline-7-sulphonate(R1) 
N
NClO2S Resorcinol, Pyridine
Heat for 45 min.
N
NSO
O
O
 
Yield of product:  2.26, Percentage yield:  80%, TLC: Benzene: Methanol(9:1); Rf =0.39 
4.2.2. Synthesis of Phenyl-2,3-diphenylquinoxaline-7-sulphonate(R2) 
N
NClO2S Phenol, Pyridine
Heat for 45 min.
N
NSO
O
O
 
Yield of product:  1.74 , Percentage yield:  75%, TLC: Benzene : Methanol(9:1); Rf =0.42 
4.2.3 Synthesis of 4-hydroxyphenyl-2,3-diphenylquinoxaline-7-sulphonate(R3) 
Yield of product:  2.20 gm, Percentage yield:  78%, TLC: Benzene: Methanol(9:1); Rf =0.9 
4.2.4 Synthesis of 4-Chlorophenyl-2,3-diphenylquinoxaline-7-sulphonate(R4) 
N
NClO2S 4-chlorophenol, Pyridine
Heat for 1.5 hr.
N
NSOCl
O
O
 
Yield of product:  2.73 gm, Percentage yield:  80%, TLC: Benzene : Methanol(9:1); Rf =0.8 
4.2.5 Synthesis of Napthalene-1-yl-2,3-diphenylquinoxaline-7-sulphonate(R5) 
Yield of product:  3.11 gm, Percentage yield:  78%, TLC: Benzene : Methanol(9:1); Rf =0.5 
4.2.6 Synthesis of Napthalene-2-yl-2,3-diphenylquinoxaline-7-sulphonate (R6) 
N
NClO2S 2-napthol, Pyridine
Heat for 2.15 hr.
N
NSO
O
O
 
Yield of product:  3.27 gm, Percentage yield:  82%, TLC: Benzene : Methanol(9:1); Rf =0.7 
Table 3: QSAR result analysis of synthesized compounds 
compound nrotb vol GPCR ligand Ion channel 
modulator 
Kinase 
inhibitor 
Nuclear receptor 
ligand 
R1 5 382.382 -0.17 -0.24 -0.35 -0.09 
R2 5 374.364 -0.2 -0.24 -0.39 -0.22 
R3 5 382.382 -0.17 -0.23 -0.36 -0.11 
R4 5 387.9 -0.19 -0.26 -0.38 -0.27 
R5 5 418.356 -0.2 -0.44 -0.30 -0.32 
R6 5 418.356 -0.17 -0.43 -0.34 -0.21 
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Table 4: Physicochemical properties of synthesized quinoxaline derivatives 
Code no. M. P. (0C) Mol. wt Rf value Percent yield Mol. formula 
R1 92 460 0.39 80 C26H18N2O4S 
R2 105 443 0.42 75 C26H17N2O3S 
R3 82 460 0.9 78 C26H18N2O4S 
R4 102 478.5 0.8 80 C26H17N2O3SCl 
R5 98 494 0.5 78 C30H20N2O3S 
R6 106 494 0.7 82 C30H20N2O3S 
 
4.3 FTIR Spectral data of synthesized quinoxaline derivatives 
N
NSO
OH
O
O
2-hydroxyphenyl-2,3-
diphenylquinoxaline-7-sulphonate 
 Fuctional group Frequency(cm-1) 
OH 3500.8 
S=O 1132.8(1180-1130) 
1330.1 ( 1370-1300) 
Mono sub. Aromatic ring 757.8 ( 735-770) 
CH aromatic 3046.60   ( 3100-3000) 
 
N
NSO
O
O
  
phenyl-2,3-diphenylquinoxaline-7-sulphonate 
Fuctional group Frequency(cm-1) 
S=O 1132.5(1180-1130) 
1339.4 ( 1370-1300) 
 C=N 1685.4(1690-1630) 
Mono sub. Aromatic ring 757.8 ( 770-735) 
CH aromatic 3045.9   ( 3100-3000) 
 
N
NSOOH
O
O
 
2-4-hydroxyphenyl-2,3-diphenylquinoxaline-7-
sulphonate 
Fuctional group Frequency(cm-1) 
S=O 1132.5(1180-1130) 
1334.6 ( 1370-1300) 
 OH 3392.3 
C=N 1647.3(1690-1620) 
CH aromatic 3036.3  ( 3100-3000) 
 
 
N
NSOCl
O
O
 
4-chlorophenyl-2,3-diphenylquinoxaline-7-
sulphonate 
Fuctional group Frequency(cm-1) 
S=O 1137.7(1180-1130) 
1339.7( 1370-1300) 
 Cl 690.2(750-500) 
Mono sub. Aromatic ring 762.3(770-735) 
CH aromatic 3046.6  ( 3100-3000) 
 
 
N
NSO
O
O
 
Napthalene-1-yl-2,3-diphenyl- 
diphenylquinoxaline-7-sulphonate 
Fuctional group Frequency(cm-1) 
S=O 1137.7(1180-1130) 
1339.7( 1370-1300) 
 C=N 1623.6(1690-1620) 
Mono sub. Aromatic ring 752.8(770-735) 
CH aromatic 3046.6  ( 3100-3000) 
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4.5 Antimicrobial Susceptibility Testing: 
Synthesized quinoxaline derivatives were subjected to 
antimicrobial susceptibility testing by well diffusion method 
against gram positive (S.aureus, 2079) and gram negative 
bacteria (E. coli, 2685). The results of quinoxaline 
derivatives in terms of zone of inhibition were as follows.
 
Table 5: Zone of inhibition against S. aureus 
Quinoxaline 
derivative 
Zone of inhibition (mm.) 
2OOµg.  S.aureus 
Zone of inhibition (mm.) 
400 µg. S.aureus 
Azithromycin (s) 18 37 
R1 - - 
R2 - - 
R3 11 21 
R4 - - 
R5 09 18 
R6 11 22 
 
Table 6: Zone of inhibition against E. coli 
Quinoxaline 
derivative 
Zone of inhibition (mm.) 200 
µg. E.coli 
Zone of inhibition (mm.) 
400 µg. E.coli 
Azithromycin (s) 17 33 
R1 - - 
R2 - - 
R3 - - 
R4 - - 
R5 07 13 
R6 06 12 
 
The concentration of derivatives used as 200 and 400 
microgram initially. When 200 µg concentrations was used 
R6 shows sensitivity towards S. aureus and R6 shows 
sensitivity towards gram negative E. coli organism. When 
400 µg used then R3, R5, and R6 shows sensitivity in case of 
gram positive organism. And in case of gram negative 
organism R5, R6 shows sensitivity. 
The promising results were obtained against S. aureus, so 
quinoxaline derivatives were found to be more sensitive 
towards gram positive than gram negative organism under 
the present experimental setup. R3, R5, R6 were slightly 
sensitive towards S. aureus. 
Azithromycin is used as Reference drug and a comparative 
study was done. As compare to reference drug all derivatives 
shows less sensitivity than S- Standard and R- quinoxaline 
derivatives respectively. 
 
 
 
200 µg/ml strain400 µg/ml strain 
Fig 1: Photographs indicating Zone of Inhibition of S. aureus&E. coli 
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4.6 Determination of MIC: 
MIC of quinoxaline derivative was determined by tube micro 
dilution technique against S.aureus and E. coli. The turbidity 
was measured by UV at about 420 nm. The results of MIC 
were found to be as follows. 
 
Table 7: Results for MIC of quinoxaline derivatives against S. aureus 
Quinoxaline Derivative Absorbance at 420 nm. 
Conc. (µg/ml) 200 400 800 1000 
S 0.865 0.851 0.621 0.271 
R6 0.797 0.736 0.542 0.204 
 
Table 1 Results for MIC of quinoxaline derivatives against E. coli 
Quinoxaline Derivative Absorbance at 420 nm. 
Conc. (µg/ml) 200 400 800 1000 
S 0.705 0.580 0.436 0.365 
R6 0.567 0.473 0.307 0.245 
 
 
5. CONCLUSION: 
The phenol derivatives were synthesized and were 
confirmed by physicochemical and spectral analysis. The 
objective of the present study was to synthesize some new 
7-sulfonate of 2, 3- Diphenyl quinoxaline which are more 
potential as antibacterial than parent quinoxalines. The 
present study was synthesis of derivatives of sulfonyl 
chloride quinoxaline and physicochemical and spectral 
characterization, in vitro antimicrobial screening against 
gram positive and gram negative bacteria. All sulfonyl 
chloride derivatives of quinoxaline were synthesized on the 
basis of elimination-addition reaction mechanism. All the 
derivatives were confirmed by TLC, IR, and 1HNMR. The 
spectral characterization revealed the formation of 
sulfonates. The results of pharmacological screenings are 
satisfactory. All the derivatives were then subjected to 
antimicrobial susceptibility testing against gram positive (S. 
aureus) and gram negative bacteria (E. coli). Also, 
antimicrobial data of quinoxaline derivatives was obtained. 
It was found that sulfonyl chloride quinoxaline derivatives 
have pronounced effect as compared to antibiotic 
(Azithromycin) present in the market against both the gram 
positive and gram negative bacteria. QSAR study gives idea 
about various descriptors of different derivatives and 
Docking gives idea about having more affinity towards 
gamma Glutamyltranspeptidase enzyme. 
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